The Notch1/Hes1 signaling pathway affects autophagy by adjusting DNA methyltransferases expression in a valproic acid-induced autism spectrum disorder model DOI Creative Commons
Yanfang Li, Liping Ma, Yanan Deng

и другие.

Neuropharmacology, Год журнала: 2023, Номер 239, С. 109682 - 109682

Опубликована: Авг. 3, 2023

Язык: Английский

The emerging role of chromatin remodelers in neurodevelopmental disorders: a developmental perspective DOI Creative Commons
Britt Mossink, Moritz Negwer, Dirk Schubert

и другие.

Cellular and Molecular Life Sciences, Год журнала: 2020, Номер 78(6), С. 2517 - 2563

Опубликована: Дек. 2, 2020

Abstract Neurodevelopmental disorders (NDDs), including intellectual disability (ID) and autism spectrum (ASD), are a large group of in which early insults during brain development result wide heterogeneous clinical diagnoses. Mutations genes coding for chromatin remodelers overrepresented NDD cohorts, pointing towards epigenetics as convergent pathogenic pathway between these disorders. In this review we detail the role NDD-associated developmental continuum progenitor expansion, differentiation, cell-type specification, migration maturation. We discuss how defects remodelling time points compound over impaired circuit establishment. particular, focus on their three largest cell populations: glutamatergic neurons, GABAergic glia cells. An in-depth understanding spatiotemporal neurodevelopment can contribute to identification molecular targets treatment strategies.

Язык: Английский

Процитировано

82

Epigenetic regulation of energy metabolism in obesity DOI Creative Commons
Wei Gao, Jiali Liu, Xiang Lü

и другие.

Journal of Molecular Cell Biology, Год журнала: 2021, Номер 13(7), С. 480 - 499

Опубликована: Июль 1, 2021

Obesity has reached epidemic proportions globally. Although modern adoption of a sedentary lifestyle coupled with energy-dense nutrition is considered to be the main cause obesity epidemic, genetic preposition contributes significantly imbalanced energy metabolism in obesity. However, variants loci identified from large-scale studies do not appear fully explain rapid increase last four five decades. Recent advancements next-generation sequencing technologies and tissue-specific effects epigenetic factors metabolic organs have advanced our understanding regulation The epigenome, including DNA methylation, histone modifications, RNA-mediated processes, characterized as mitotically or meiotically heritable changes gene function without alteration sequence. Importantly, modifications are reversible. Therefore, comprehensively landscape could unravel novel molecular targets for treatment. In this review, we summarize current knowledge on roles such methylation acetylation, processes regulating metabolism. We also discuss therapeutic agents

Язык: Английский

Процитировано

61

The disordered N-terminal domain of DNMT3A recognizes H2AK119ub and is required for postnatal development DOI

Tianpeng Gu,

Dapeng Hao, Junsung Woo

и другие.

Nature Genetics, Год журнала: 2022, Номер 54(5), С. 625 - 636

Опубликована: Май 1, 2022

Язык: Английский

Процитировано

50

NSD1 deposits histone H3 lysine 36 dimethylation to pattern non-CG DNA methylation in neurons DOI Creative Commons
Nicole Hamagami, Dennis Y. Wu,

Adam W. Clemens

и другие.

Molecular Cell, Год журнала: 2023, Номер 83(9), С. 1412 - 1428.e7

Опубликована: Апрель 24, 2023

Язык: Английский

Процитировано

24

Dissecting the Relationship Between Neuropsychiatric and Neurodegenerative Disorders DOI

Rohan Gupta,

Dia Advani, Divya Yadav

и другие.

Molecular Neurobiology, Год журнала: 2023, Номер 60(11), С. 6476 - 6529

Опубликована: Июль 17, 2023

Язык: Английский

Процитировано

24

Tissue-specific roles of de novo DNA methyltransferases DOI Creative Commons

Dániel M. Tóth,

Flóra Szeri, Mária Ashaber

и другие.

Epigenetics & Chromatin, Год журнала: 2025, Номер 18(1)

Опубликована: Янв. 17, 2025

DNA methylation, catalyzed by methyltransferases (DNMT), plays pivotal role in regulating embryonic development, gene expression, adaption to environmental stress, and maintaining genome integrity. DNMT family consists of DNMT1, DNMT3A, DNMT3B, the enzymatically inactive DNMT3L. DNMT3A DNMT3B establish novel methylation patterns maintained DNMT1 during replication. Genetic variants cause rare diseases such as Tatton-Brown-Rahman ICF syndromes. Additionally, somatic mutations common conditions osteoarthritis, osteoporosis, clonal hematopoiesis indeterminate potential (CHIP), hematologic malignancies, cancer. While DNMTs have been extensively studied vitro, early development disease, their detailed physiologic roles remain less understood vivo investigations are hindered or perinatal lethality knockout mice. To circumvent this problem, tissue-specific Dnmt3a Dnmt3b knockouts were engineered. This review explores diverse molecular across various organs cell types characterizes phenotype We provide a comprehensive collection over forty models generated cre recombinase. highlight distinct functions germ cells, uterus, hematopoietic differentiation, musculoskeletal visceral organs, nervous system. Our findings indicate that primarily regulates while is crucial for cartilage homeostasis ossification. emphasize context-dependent demonstrate they also complement maintenance methyltransferase activity. Overall, expression tissues insights into therapeutic applications treating neurologic diseases, cancer, osteoporosis.

Язык: Английский

Процитировано

2

Identification of selective SWI/SNF dependencies in enzalutamide-resistant prostate cancer DOI Creative Commons
Bengul Gokbayrak, Umut Berkay Altıntaş, Shreyas Lingadahalli

и другие.

Communications Biology, Год журнала: 2025, Номер 8(1)

Опубликована: Фев. 4, 2025

Enzalutamide is a potent second-generation antiandrogen commonly used to treat hormone-sensitive and castration-resistant prostate cancer (CRPC) patients. While initially effective, the disease almost always develops resistance. Given that many enzalutamide-resistant tumors lack specific somatic mutations, there strong evidence epigenetic factors can cause enzalutamide To explore how resistance arises, we systematically test all modifiers in several models of with custom CRISPR library. From this, identify validate SMARCC2, core component SWI/SNF complex, selectivity essential models. We show chromatin occupancy SMARCC2 BRG1 expanded at regions overlap CRPC-associated transcription are accessible CRPC clinical samples. Overall, our study reveals regulatory role for supports feasibility targeting complex late-stage PCa. An epigenome-focused screen identified unique dependency against complexes potentially mediated by an expansion their binding regions.

Язык: Английский

Процитировано

1

Single-cell technology grows up: Leveraging high-resolution omics approaches to understand neurodevelopmental disorders DOI Creative Commons
Joseph D. Dougherty, Simona Sarafinovska, Sneha Chaturvedi

и другие.

Current Opinion in Neurobiology, Год журнала: 2025, Номер 92, С. 102990 - 102990

Опубликована: Март 3, 2025

Язык: Английский

Процитировано

1

MeCP2 is a microsatellite binding protein that protects CA repeats from nucleosome invasion DOI
Abdulkhaleg Ibrahim, Christophe Papin,

Kareem Mohideen-Abdul

и другие.

Science, Год журнала: 2021, Номер 372(6549)

Опубликована: Июнь 25, 2021

MeCP2 binds hydroxymethylated CA repeats Despites of decades research on the Rett syndrome protein MeCP2, its function remains unclear. Ibrahim et al. show that is a cytosine-adenosine (CA) repeat-binding modulates chromatin architecture at distance from transcription start site (see Perspective by Zhou and Zoghbi). accumulates spreads around modified competes for nucleosome occupancy. Loss results in widespread increase density inside lamina-associated domains transcriptional dysregulation genes enriched repeats. These shed light underlying molecular mechanism syndrome, severe disease associated with mutations MeCP2. Science , abd5581, this issue p. eabd5581 ; see also abj5027, 1390

Язык: Английский

Процитировано

50

MicroRNAs in the Onset of Schizophrenia DOI Creative Commons

Kristen T. Thomas,

Stanislav S. Zakharenko

Cells, Год журнала: 2021, Номер 10(10), С. 2679 - 2679

Опубликована: Окт. 6, 2021

Mounting evidence implicates microRNAs (miRNAs) in the pathology of schizophrenia. These small noncoding RNAs bind to mRNAs containing complementary sequences and promote their degradation and/or inhibit protein synthesis. A single miRNA may have hundreds targets, targets are overrepresented among schizophrenia-risk genes. Although schizophrenia is a neurodevelopmental disorder, symptoms usually do not appear until adolescence, most patients receive diagnosis late adolescence or early adulthood. However, few studies examined miRNAs during this critical period. First, we examine that pathway dynamic throughout adulthood regulate processes neurodevelopment aberrant with Next, implicating conversion psychosis, including schizophrenia-associated nucleotide polymorphism MIR137HG strongest known predictors age onset Finally, how hemizygosity for DGCR8, which encodes an obligate component complex synthesizes precursors, contribute psychosis 22q11.2 microdeletions animal models disorder can help us understand many roles

Язык: Английский

Процитировано

42